Economists split on next Bank of Canada decision after July inflation report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
BuildDirect.com Technologies Inc. Second Quarter 2025 Conference Call
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - Technologies Inc. (TSXV: BILD) (OTCQB: BDCTF) ("BuildDirect" or the "Company"), a leading omnichannel building material retailer, today announced that the Company will report its second quarter 2025 financial results before the market open on Thursday, August 28, 2025. Management will host a conference call and webcast to discuss the Company's financial results at 11:00 AM (PDT) / 2:00 PM (EDT) on Thursday, August 28, 2025. BuildDirect Second Quarter 2025 Financial Results Conference Call Date: Thursday, August 28, 2025Time: 11:00 AM (PDT) / 2:00 PM (EDT)Live Webinar: The Company will host a Q&A session during the webinar. The replay will be available approximately 24 hours after the completion of the live webinar on the Investor Relations section of BuildDirect's website at About BuildDirect: BuildDirect (TSXV: BILD) is a growing omnichannel building material retailer. BuildDirect connects North American home improvement B2B and B2C organizations, and homeowners with quality building materials and services through its robust global supply chain network. BuildDirect's growth trajectory, strong product offering, and proprietary heavyweight delivery network are delivering value today, solidifying its position as an innovative player in the home improvement industry. For more information, visit For further information: BuildDirect Investor Relationsir@ Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit
Yahoo
a few seconds ago
- Yahoo
Self-driving vehicle startup Nuro valued at $6 billion in late-stage funding round
(Reuters) -Self-driving vehicle startup Nuro closed its late-stage funding round on Thursday, raising $203 million at a $6 billion valuation from new investors Uber and Nvidia alongside returning backers. The latest tranche of $97 million follows the $106 million announced in April, which included investors such as T. Rowe Price, Fidelity, and Tiger Global. The company's valuation in the latest funding round is lower than the $8.6 billion it was valued at in 2021, according to Pitchbook data. Many startups that became unicorns during the 2021 funding boom are now raising capital at lower valuations as investors' attention turns toward artificial intelligence. "The change reflects broader market conditions and this is a strong outcome for the current market environment," a Nuro spokesperson said. Nuro has been pushing to scale its self-driving platform and expand commercial partnerships. Founded in 2016, Nuro has pivoted from delivery robots to licensing its Nuro Driver technology for use in robotaxis, commercial fleets, and personal vehicles. Nuro partnered with EV maker Lucid and Uber to launch a global robotaxi service. Uber plans to deploy over 20,000 Lucid Gravity SUVs equipped with Nuro's system across dozens of markets over six years starting in 2026.
Yahoo
a few seconds ago
- Yahoo
Longleaf Partners Small-Cap Fund Trimmed Oscar Health (OSCR) on Strength
Longleaf Partners, managed by Southeastern Asset Management, released its 'Small-Cap Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.70% in the second quarter, compared to the Russell 3000's 10.99% return and the Russell 2000's 8.50% gain. For more information on the fund's best picks in 2025, please check its top five holdings. In its second-quarter 2025 investor letter, Longleaf Partners Small-Cap Fund highlighted stocks such as Oscar Health, Inc. (NYSE:OSCR). Oscar Health, Inc. (NYSE:OSCR) is a US-based healthcare technology company. The one-month return of Oscar Health, Inc. (NYSE:OSCR) was -3.78%, and its shares lost 9.86% of their value over the last 52 weeks. On August 20, 2025, Oscar Health, Inc. (NYSE:OSCR) stock closed at $15.27 per share, with a market capitalization of $3.948 billion. Longleaf Partners Small-Cap Fund stated the following regarding Oscar Health, Inc. (NYSE:OSCR) in its second quarter 2025 investor letter: "Oscar Health, Inc. (NYSE:OSCR) – Health insurance and software company Oscar was a top contributor for the quarter. The company delivered a solid quarter operationally, effectively managing what was within its control despite market sentiment experiencing wild swings, largely driven by the latest draft of the Trump bill. We remain confident in the long-term potential for this company considering its differentiated offering for its members, and our aligned management partners who are on offense with a great balance sheet. That said, we trimmed our position this quarter when sentiment was most favorable." Oscar Health, Inc. (NYSE:OSCR) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 41 hedge fund portfolios held Oscar Health, Inc. (NYSE:OSCR) at the end of the first quarter, which was 43 in the previous quarter. While we acknowledge the potential of Oscar Health, Inc. (NYSE:OSCR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Oscar Health, Inc. (NYSE:OSCR) and shared the list of high growth low debt stocks to invest in. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
